{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-001482","form_type":"8-K","ticker":"QNCX","cik":"0001662774","company_name":"Quince Therapeutics, Inc.","filed_at":"2024-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.026991+00:00","generated_at":"2026-06-07T04:43:02.825254+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Quince Therapeutics regains Nasdaq minimum bid price compliance","bullets":["Nasdaq notified Quince on Dec 4, 2023 of non-compliance due to bid price below $1.00 for 30 consecutive days.","On Dec 29, 2023, Nasdaq confirmed compliance after closing bid price ≥ $1.00 for 13 consecutive business days.","The matter is closed; Quince remains listed on the Nasdaq Global Select Market."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-001482","json":"https://secwatch.observer/filing/0001193125-24-001482.json","markdown":"https://secwatch.observer/filing/0001193125-24-001482.md","text":"https://secwatch.observer/filing/0001193125-24-001482.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1662774/000119312524001482/0001193125-24-001482-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1662774/000119312524001482/d641060d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T04:43:02.825254+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}